Syros Pharmaceuticals, Inc.
Industry: Biotechnology (See others in industry)
Address:
35 Cambridge Park Drive
Cambridge, MA, 02140
Phone: 617-744-1340
Cambridge, MA, 02140
Phone: 617-744-1340
Filings
| Date | FilingType | Incremental Cash | Link to Raw Filing | |||
|---|---|---|---|---|---|---|
| 2022-09-21 | New | $129,843,346 | $129,843,346 | Equity Only | 06b | SEC link |
| 2020-12-17 | New | $90,490,000 | $90,490,000 | Equity Only | 06b | SEC link |
| 2018-02-09 | Amended | $11,380,018 | $1,380,023 | Equity Only | 06b | SEC link |
| 2018-01-17 | New | $9,999,995 | $9,999,995 | Equity Only | 06b | SEC link |
| 2014-10-24 | New | $53,149,996 | $53,149,996 | Equity Only | 06b | SEC link |
| 2013-04-22 | New | $10,000,000 | $10,000,000 | Equity Only | 06 | SEC link |
| 2012-08-22 | New | $1,250,000 | $1,250,000 | Equity Only | 06 | SEC link |
Directors and Executives (Current and Past)
| Name | Role |
|---|---|
| Noubar B. Afeyan | Director |
| Srinivas Akkaraju | Director |
| Mark Alles | Director |
| Stephane Bancel | Director |
| James E. Bradner | Director |
| Conely Chee | Executive |
| Douglas Cole | Director |
| Jorge Conde | Executive |
| Deborah Dunsire | Director |
| Sue Gail Eckhardt | Director |
| Marsha Fanucci | Director |
| Joseph Ferra, Jr. | Executive |
| Jason Haas | Executive |
| Amir Nashat | Director |
| Robert Nelsen | Director |
| Andrew Oh | Director |
| Eric Olson | Executive |
| Sanj Patel | Director |
| Gerald Quirk | Executive |
| David Roth | Executive |
| Vicki Sato | Director |
| Phillip Sharp | Director |
| Philip Sharp | Director |
| Nancy Simonian | Director, Executive |
| Jeremy Springhorn | Executive |
| Kristin Stephens | Executive |
| Timothy C. Tyson | Director |
| Harry Wilcox Iii | Executive |
| Peter Wirth | Director |
| Richard A. Young | Director |